Transcript Document
Group H • Research Priorities – For patients with MCC, approaches to identify the various disease-specific and summary patient reported outcomes (PRO) that are valid, practical, and actionable? • E.g. Patient with CAD, AF, CHF SF-12 vs SAQ + AFEQT + KCCQ…? • What about non-cardiac? – How should performance measures for patients with MCC be ATTRIBUTED to single providers vs measuring how well a SYSTEM cares for a specific patients? – Evaluate strategies for effective communication of evidence-based therapies AND the uncertainty that remains – Pairing research of PRO measurement with studies targeting improvement – Identifying new techniques and technology for effective patient-doctor communication and engagement while consolidating and coordinating care among multiple specialties. Group H • What opportunities are available for development and promulgation of performance measures that are better aligned with patient-centered health outcomes, and what research is needed to support such measures? – Need clearer understanding and more research into how a particular measurement rises to the level of becoming a “performance measure” worthy of enforcement/incentive? – Funding for the PROMISE initiative to validate measures in older patients with MCC, CVD – Communication of selected PRO to primary care physician (and entire health care team), regardless of clinical context from which it arose, with clearer understanding of where the PRO measurement places someone along a clinical trajectory